HCM II Acquisition (NASDAQ:HOND - Get Free Report)'s stock had its "sell (d-)" rating restated by stock analysts at
Weiss Ratings in a research note issued on Wednesday,
Weiss Ratings reports.
HCM II Acquisition Trading Down 1.7%
HCM II Acquisition stock opened at $17.09 on Wednesday. HCM II Acquisition has a 12-month low of $9.90 and a 12-month high of $19.60. The business's 50-day simple moving average is $12.86 and its 200 day simple moving average is $11.68.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in the stock. North Capital Inc. acquired a new position in HCM II Acquisition in the second quarter valued at about $67,000. Patriot Financial Group Insurance Agency LLC bought a new stake in shares of HCM II Acquisition in the 2nd quarter valued at about $209,000. Mizuho Securities USA LLC bought a new stake in shares of HCM II Acquisition in the 1st quarter valued at about $271,000. FNY Investment Advisers LLC increased its stake in shares of HCM II Acquisition by 41,400.0% in the 2nd quarter. FNY Investment Advisers LLC now owns 41,500 shares of the company's stock valued at $460,000 after acquiring an additional 41,400 shares during the last quarter. Finally, JPMorgan Chase & Co. acquired a new position in HCM II Acquisition during the second quarter valued at approximately $552,000.
HCM II Acquisition Company Profile
(
Get Free Report)
HCM II Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 4, 2024 and is headquartered in Stamford, CT.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HCM II Acquisition, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCM II Acquisition wasn't on the list.
While HCM II Acquisition currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.